LifeSci Acquisition III, the third blank check company formed by LifeSci Capital targeting the healthcare industry, filed on Friday with the SEC to raise up to $75 million.
The New York, NY-based company plans to raise $75 million by offering 7.5 million shares at $10. The company is not offering units with warrants attached. At the proposed deal size, LifeSci Acquisition III would command a market value of $94 million.
The company is led by CEO and Chairman Andrew McDonald and COO and Director Michael Rice, who are Founding Partners at healthcare-dedicated investment bank LifeSci Capital. CFO and Director David Dobkin is currently a Managing Director at LifeSci Capital. The SPAC plans to target the biopharma, medical technology, digital health, and healthcare services sectors in North America or Europe.
LifeSci Acquisition III was founded in 2019 and plans to list on the Nasdaq under the symbol LSAC. The company filed confidentially on June 28, 2021. LifeSci Capital and Ladenburg Thalmann are the joint bookrunners on the deal.
